Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis (Q40633796)

22 September 2017

title

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis (English)

1 reference

22 September 2017

Nishikawa M

1 reference

22 September 2017

Ichiyama T

1 reference

22 September 2017

Hayashi T

1 reference

22 September 2017

Ouchi K

1 reference

22 September 2017

Furukawa S

1 reference

22 September 2017

publication date

1 August 1999

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

583-586

1 reference

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Intravenous immunoglobulin in two children with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

The Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Acute disseminated encephalomyelitis: response to intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Anti-idiotypic immunity and autoimmunity. I. In vitro and in vivo effects of anti-idiotypic antibodies to spontaneously occurring autoantibodies to rat thyroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Steroid-responsive encephalomyelitis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Plasmapheresis in fulminant acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2899%2900042-9

7 January 2021

10.1016/S0887-8994(99)00042-9

Identifiers

DOI

1 reference

22 September 2017

1 reference